Efficacy of Catheter Ablation for Nonparoxysmal Atrial Fibrillation Academic Article

abstract

• Clinical Question: Is catheter ablation better than antiarrhythmic drugs for the prevention of nonparoxysmal atrial fibrillation? Bottom Line: Radiofrequency catheter ablation was found to be superior to antiarrhythmic drugs in preventing recurrences of nonparoxysmal atrial fibrillation and reducing hospital admissions.

authors

• Amit, Guy
• Nyong, Jonathan
• Morillo, Carlos A

status

• published 

publication date

• July 1, 2017

has subject area

• Anti-Arrhythmia Agents (MeSH)
• Atrial Fibrillation (MeSH)
• Catheter Ablation (MeSH)
• Hospitalization (MeSH)
• Humans (MeSH)
• Recurrence (MeSH)
• Treatment Outcome (MeSH)

published in

• JAMA Cardiology  Journal

keywords

• Anti-Arrhythmia Agents
• Atrial Fibrillation
• Catheter Ablation
• Hospitalization
• Humans
• Recurrence
• Treatment Outcome

Digital Object Identifier (DOI)

• 10.1001/jamacardio.2017.0901

PubMed ID

• 28423144

start page

• 812

end page

• 812

volume

• 2

issue

• 7